|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000090661 |
Summary for CERS4 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000090661 | Gene symbol | CERS4 |
| Gene name | ceramide synthase 4 | |
| HGNC | 23747 | |
| Entrez ID | 79603 | |
| Gene type | protein_coding | |
| Synonyms | CERS4|FLJ12089|Trh1 | |
| UniProtAcc | Q9HA82 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for CERS4 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| CERS4 | 1.10e+03 | -1.13e+00 | 3.36e-01 | -3.37e+00 | 7.63e-04 | 2.22e-03 | STAD |
| CERS4 | 1.95e+03 | -2.45e+00 | 4.74e-01 | -5.18e+00 | 2.25e-07 | 1.86e-06 | CHOL |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for CERS4 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for CERS4 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| SARC | cg06686742 | chr19:8208621 | CGI:chr19:8208646-8209036 | promoter,gene body | 6.45e-01 | 5.09e-01 | 3.92e+00 | 8.73e-05 | 4.55e-04 | 1.37e-01 |
| ESCA | cg06686742 | chr19:8208621 | CGI:chr19:8208646-8209036 | promoter,gene body | 3.95e-01 | 2.39e-01 | 3.48e+00 | 5.08e-04 | 2.44e-03 | 1.56e-01 |
| CHOL | cg06686742 | chr19:8208621 | CGI:chr19:8208646-8209036 | promoter,gene body | 7.52e-01 | 5.82e-01 | 2.20e+00 | 2.80e-02 | 3.90e-02 | 1.70e-01 |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUSC | cg06686742 | chr19:8208621 | CGI:chr19:8208646-8209036 | promoter,gene body | 2.73e-01 | 5.25e-01 | -3.82e+00 | 1.36e-04 | 8.00e-04 | -2.52e-01 |
| LUSC | cg25712758 | chr19:8206295 | CGI:chr19:8208646-8209036 | promoter | 8.39e-01 | 9.40e-01 | -2.87e+00 | 4.06e-03 | 6.99e-03 | -1.01e-01 |
| COAD | cg25712758 | chr19:8206295 | CGI:chr19:8208646-8209036 | promoter | 7.78e-01 | 9.05e-01 | -2.57e+00 | 1.02e-02 | 1.45e-02 | -1.26e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg25712758 | chr19:8206295 | CGI:chr19:8208646-8209036 | promoter | 7.69e-01 | 9.23e-01 | -5.32e+00 | 1.03e-07 | 2.11e-07 | -1.53e-01 |
| LIHC | cg06686742 | chr19:8208621 | CGI:chr19:8208646-8209036 | promoter,gene body | 5.89e-01 | 4.13e-01 | 2.69e+00 | 7.12e-03 | 1.06e-02 | 1.76e-01 |
Top |
Exon skipping events with PSI in TCGA for CERS4 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for CERS4 |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for CERS4 |
TFs related to CERS4.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
CERS4 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for CERS4 |
RBPs related to ES in CERS4.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BRCA | ZC3H10 | exon_skip_301560 | 5.78e+00 | 3.51e-03 | 6.72e+00 | 9.80e-01 | Female-biased |
| PCPG | TARDBP | exon_skip_301464 | 7.28e+00 | 9.86e-01 | 6.80e+00 | 1.60e-03 | Male-biased |
| KICH | G3BP2 | exon_skip_301653 | 9.33e+00 | 9.92e-01 | 8.93e+00 | 4.36e-03 | Male-biased |
CERS4 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs7254269 | chr19:15166618:T:A | - | -0.129030070823564 | 0.0406605723926542 | LUSC | Female-baised eQTL |
| rs62123732 | chr19:2617745:G:T | - | 0.150984443049581 | 0.0043725082908944 | STAD | Female-baised eQTL |
| rs4134816 | chr19:7628865:A:G | - | 0.0983775868028808 | 0.0166136443133214 | STAD | Female-baised eQTL |
| rs12983873 | chr19:6997590:G:C | - | 0.107011671464597 | 0.0376490186346295 | KIRC | Female-baised eQTL |
| rs35540322 | chr19:3007942:G:A | - | 0.21804004504956 | 0.0223314156667378 | BLCA | Female-baised eQTL |
| rs72988909 | chr19:3008153:G:A | - | 0.21804004504956 | 0.0223314156667378 | BLCA | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs12609323 | chr19:6380012:G:A | - | 0.0837483238907403 | 0.0272657381891167 | LIHC | Male-baised eQTL |
| rs3745573 | chr19:6383526:G:A | - | 0.0837483238907403 | 0.0272657381891167 | LIHC | Male-baised eQTL |
| rs8102989 | chr19:6386631:G:C | - | 0.0837483238907403 | 0.0272657381891167 | LIHC | Male-baised eQTL |
| rs869918 | chr19:6376711:A:G | - | 0.0814506203324983 | 0.032811771613383 | LIHC | Male-baised eQTL |
| rs55779804 | chr19:6371649:G:C | - | 0.0815822693589979 | 0.03379110746819 | LIHC | Male-baised eQTL |
| rs60965685 | chr19:6389006:C:G | - | 0.0809061519961208 | 0.0338942192790473 | LIHC | Male-baised eQTL |
| rs113073049 | chr19:17041310:C:T | - | 0.0672664738755501 | 0.00636442471405338 | KIRC | Male-baised eQTL |
| rs76678407 | chr19:17042442:C:T | - | 0.0660659268732081 | 0.00799550119431844 | KIRC | Male-baised eQTL |
| rs1143699 | chr19:5210751:G:A | - | 0.0649675191933808 | 0.0118693489900514 | KIRC | Male-baised eQTL |
| rs17454516 | chr19:17053363:C:T | - | 0.0621483526150769 | 0.0126379002449325 | KIRC | Male-baised eQTL |
| rs77491415 | chr19:17055497:C:T | - | 0.0621483526150769 | 0.0126379002449325 | KIRC | Male-baised eQTL |
| rs78090584 | chr19:17056226:C:T | - | 0.0621483526150769 | 0.0126379002449325 | KIRC | Male-baised eQTL |
| rs111986055 | chr19:17068145:G:A | - | 0.0624161557372445 | 0.0126593169316845 | KIRC | Male-baised eQTL |
| rs112379173 | chr19:5207281:C:T | - | 0.0670984229809185 | 0.0145133414044672 | KIRC | Male-baised eQTL |
| rs10469470 | chr19:17076708:T:G | - | 0.0599014490607956 | 0.0164399843388698 | KIRC | Male-baised eQTL |
| rs10409542 | chr19:9246240:T:G | - | 0.0724935659053286 | 0.0343153839187005 | KIRC | Male-baised eQTL |
| rs10410267 | chr19:9247789:T:C | - | 0.0724234286104588 | 0.0347887738167519 | KIRC | Male-baised eQTL |
| rs73920720 | chr19:9249221:T:C | - | 0.0724234286104588 | 0.0347887738167519 | KIRC | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| exon_skip_301666 | chr19:8257878:8257985 | Frame-shift | rs4147644 | chr19:8322114:T:C | Distant downstream | -0.0338656002264159 | 0.0125378405609242 | LUAD | Male-baised sQTL |
| exon_skip_301666 | chr19:8257878:8257985 | Frame-shift | rs7253567 | chr19:8323526:G:A | Distant downstream | -0.033863881458967 | 0.0127006410290374 | LUAD | Male-baised sQTL |
| exon_skip_301666 | chr19:8257878:8257985 | Frame-shift | rs10416635 | chr19:8324280:C:T | Distant downstream | -0.0334693346507637 | 0.020813421152762 | LUAD | Male-baised sQTL |
| exon_skip_301666 | chr19:8257878:8257985 | Frame-shift | rs10412891 | chr19:8327369:C:T | Distant downstream | -0.0336588002160972 | 0.0263024084680748 | LUAD | Male-baised sQTL |
| exon_skip_301666 | chr19:8257878:8257985 | Frame-shift | rs3760685 | chr19:8324127:C:A | Distant downstream | -0.0304667218468723 | 0.0303639334962877 | LUAD | Male-baised sQTL |
| exon_skip_301666 | chr19:8257878:8257985 | Frame-shift | rs10409529 | chr19:8325832:A:G | Distant downstream | -0.0314156431596035 | 0.0420541452955257 | LUAD | Male-baised sQTL |
| exon_skip_301560 | chr19:8251075:8251249 | 5CDS-5UTR | rs3813780 | chr19:8096726:C:T | Distant upstream | -0.0285262590654621 | 0.0306780000967588 | LGG | Male-baised sQTL |
| exon_skip_301666 | chr19:8257878:8257985 | Frame-shift | rs8110054 | chr19:8175529:A:G | Distant upstream | -0.0179302862646217 | 0.0170947589250772 | HNSC | Male-baised sQTL |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| exon_skip_301666 | chr19:8257878:8257985 | cg16618417 | chr19:7470640 | Distant upstream | 0.163089377394293 | 2.7369689311175e-06 | 0.35570488910386716 | 1.455369974996616e-09 | Frame-shift | LUSC |
| exon_skip_301666 | chr19:8257878:8257985 | cg24876035 | chr19:7617883 | Distant upstream | 0.163089377394293 | 2.7369689311175e-06 | 0.3178036280829234 | 8.020941164535548e-08 | Frame-shift | LUSC |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of CERS4 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |